DELAYED-HYPERSENSITIVITY IN PRIMARY AND SECONDARY HYPERPARATHYROIDISM - TREATMENT WITH ACTIVE VITAMIN-D

被引:5
作者
LIND, L [1 ]
WENGLE, B [1 ]
SORENSEN, OH [1 ]
LJUNGHALL, S [1 ]
机构
[1] UNIV HOSP UPPSALA,DEPT INTERNAL MED GAVLE,S-75185 UPPSALA,SWEDEN
来源
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY | 1990年 / 95卷 / 02期
关键词
Delayed Hypersensitivity; Hyperparathyroidism; Vitamin D;
D O I
10.1055/s-0029-1210964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vitamin D endocrine system, besides its traditional role in mineral metabolism, also affects the immune system. A recent study demonstrated that vitamin D supplementation restored a blunted delayed hypersensitivity response (DH) in elderly vitamin D-deficient subjects. In the present study the DH, as measured by the tuberculin test (PPD), was studied in two groups of patients with a disturbed vitamin D system, i.e. primary hyperparathyroidism (HPT) and secondary HPT due to chronic renal failure. A significant reduction in DH was found in the patients with chronic renal failure when compared to control subjects (4.1 ± 5.3 vs 12 ± 9.3 mm, p < 0.05) whereas only a non-significant tendency to a reduced DH was seen in the HPT patients (9.5 ± 9.2 mm). Treatment with alphacalcidol, a synthetic analogue to the active vitamin D metabolite over 3—6 months did not affect the DH in any of the hyperparathyroid patient groups. Thus it seems likely that other factors than vitamin D were involved in their reduced DH response. © 1990, J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart, New York. All rights reserved.
引用
收藏
页码:271 / 274
页数:4
相关论文
共 16 条
[1]  
BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1302
[2]   SUCCESSFUL BONE-MARROW TRANSPLANTATION FOR INFANTILE MALIGNANT OSTEOPETROSIS [J].
COCCIA, PF ;
KRIVIT, W ;
CERVENKA, J ;
CLAWSON, C ;
KERSEY, JH ;
KIM, TH ;
NESBIT, ME ;
RAMSAY, NKC ;
WARKENTIN, PI ;
TEITELBAUM, SL ;
KAHN, AJ ;
BROWN, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (13) :701-708
[3]  
GRAY TK, 1985, SURV IMMUNOL RES, V4, P200
[4]   SERUM CONCENTRATIONS OF METABOLITES OF VITAMIN-D IN PATIENTS WITH CHRONIC-RENAL-FAILURE (CRF) - CONSEQUENCES FOR THE TREATMENT WITH 1-ALPHA-HYDROXY-DERIVATIVES [J].
JUTTMANN, JR ;
BUURMAN, CJ ;
DEKAM, E ;
VISSER, TJ ;
BIRKENHAGER, JC .
CLINICAL ENDOCRINOLOGY, 1981, 14 (03) :225-236
[5]   INVESTIGATION OF CELL LINEAGE IN BONE USING A CHIMAERA OF CHICK AND QUAIL EMBRYONIC TISSUE [J].
KAHN, AJ ;
SIMMONS, DJ .
NATURE, 1975, 258 (5533) :325-327
[6]   ROLE OF 1ALPHA,25-DIHYDROXYVITAMIN-D IN MEDIATION OF INTESTINAL HYPERABSORPTION OF CALCIUM IN PRIMARY HYPERPARATHYROIDISM AND ABSORPTIVE HYPERCALCIURIA [J].
KAPLAN, RA ;
HAUSSLER, MR ;
DEFTOS, LJ ;
BONE, H ;
PAK, CYC .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (05) :756-760
[7]   SUPPRESSION OF SERUM PARATHYROID-HORMONE LEVELS BY INTRAVENOUS ALPHACALCIDOL IN UREMIC PATIENTS ON MAINTENANCE HEMODIALYSIS - A PILOT-STUDY [J].
LIND, L ;
WENGLE, B ;
WIDE, L ;
WREGE, U ;
LJUNGHALL, S .
NEPHRON, 1988, 48 (04) :296-299
[8]  
LIND L, 1989, ACTA ENDOCRINOL-COP, V20, P250
[9]   DEFECTIVE NEUTROPHIL MOTILITY IN HYPOVITAMINOSIS-D RICKETS [J].
LORENTE, F ;
FONTAN, G ;
JARA, P ;
CASAS, C ;
GARCIARODRIGUEZ, MC ;
OJEDA, JA .
ACTA PAEDIATRICA SCANDINAVICA, 1976, 65 (06) :695-699
[10]   MEASUREMENT OF CIRCULATING 1,25-DIHYDROXYVITAMIN-D IN MAN - CHANGES IN SERUM CONCENTRATIONS DURING TREATMENT WITH 1-ALPHA-HYDROXYCHOLECALCIFEROL [J].
LUND, B ;
LUND, B ;
SORENSEN, OH .
ACTA ENDOCRINOLOGICA, 1979, 91 (02) :338-350